Article Details

Japan approves AstraZeneca's Calquence for adult patients with treatment-naïve CLL

Retrieved on: 2022-12-29 08:37:03

Tags for this article:

Click the tags to see associated articles and topics

Japan approves AstraZeneca's Calquence for adult patients with treatment-naïve CLL. View article details on hiswai: https://www.expresspharma.in/japan-approves-astrazenecas-calquence-for-adult-patients-with-treatment-naive-cll/

Excerpt

Japan has approved AstraZeneca's Calquence (acalabrutinib), for the treatment of adult patients with treatment-naïve Chronic Lymphocytic Leukaemia ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up